A Study on the Diagnostic Value of the Methacholine Choline Provocation Test in the Asthmatic Population
NCT ID: NCT05870436
Last Updated: 2023-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1100 participants
OBSERVATIONAL
2023-05-19
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Evaluate the Sensitivity and Specificity of Inhaled Methacholine in Bronchial Provocation Test
NCT05634473
A Study to Evaluate Efficacy and Safety of Methacholine Chloride Challenge Test in Diagnosis of Adult Asthma
NCT02100267
A Comparative Bronchial Provocation Study With Mannitol and Methacolinie in a Korean Population
NCT02104284
Bronchodilating and Bronchoprotective Effects of Deep Inspirations
NCT01659476
A Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China
NCT06422663
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Positive group
The group that conducted the Methacholine Choline Provocation Test with Positive result
Methacholine Choline Provocation Test
Perform methacholine choline provocation test according to the protocol
Negative group
The group that conducted the Methacholine Choline Provocation Test with negative result
Methacholine Choline Provocation Test
Perform methacholine choline provocation test according to the protocol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Methacholine Choline Provocation Test
Perform methacholine choline provocation test according to the protocol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* clinically evaluated as suspected asthma but have not been previously diagnosed as asthma and require a bronchial provocation test
* Basal lung function FEV1 ≥ 60%
* Meet the requirements for conducting bronchial excitation tests and pulmonary ventilation examinations
* Not currently suffering from or accompanied by other respiratory diseases, including allergic rhinitis, chronic obstructive pulmonary disease, chronic bronchitis, etc.
Stage II study:
* Basal lung function FEV1 ≥ 60%
* Meet the requirements for conducting bronchial excitation tests and pulmonary ventilation examinations
Exclusion Criteria
* Definite hypersensitivity reaction to inhaled stimulants or salbutamol or unexplained urticaria
* Severe impairment of basal pulmonary ventilation (FEV1 \< 60% of expected value %, or \< 1 L in adults)
* Poor cooperation with basal pulmonary function tests that do not meet quality control requirements
* Other conditions that make a bronchial provocation test or pulmonary ventilation function test inappropriate (e.g., recent presence of severe cardiovascular disease, seizures, uncontrolled hypertension, etc.)
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
INDUSTRY
jingping Zheng
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
jingping Zheng
Chief Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
yi Gao, PhD
Role: PRINCIPAL_INVESTIGATOR
The First Hospital of Guangzhou Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Chao-yang Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Songshan General Hospital
Chongqing, Chongqing Municipality, China
The First Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Henan Provincial People's Hospital
Zhengzhou, Henan, China
Tongji Hospital,Tongji Medical College of Hust
Wuhan, Hubei, China
West China Hospital of Sichuan University
Chengdu, Sichaun, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
yi Gao
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
yong Lu, Master
Role: primary
qianli Ma, PhD
Role: primary
jingping Zheng
Role: primary
xiaoju Zhang, PhD
Role: primary
tao Wang, PhD
Role: primary
binmiao Liang, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SX20221101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.